Takentogether, we expect that the stabilized, monomeric CD19-ECD variantsgenerated in this study will be highly useful tools to address variousimportant questions and limitations in CD19-directed cancer immunotherapies,as well as in basic, mechanistic studies on this important B cellsurface protein. Here, CD19 is linked to cancer.